TY - GEN
T1 - In-vivo fluorescence lifetime tomography for detection and quantification of programmed death ligand-1
AU - Pal, Rahul
AU - Krishnamoorthy, Murali
AU - Matsui, Aya
AU - Morita, Satoru
AU - Taniguchi, Hajime
AU - Kang, Homan
AU - Choi, Hak Soo
AU - Duda, Dan G.
AU - Kumar, Anand T.N.
N1 - Publisher Copyright:
© 2024 The Author(s).
PY - 2024
Y1 - 2024
N2 - Cancer immunotherapy relies on PD-L1 expression, often assessed through immunohistochemistry, offering limited insights. In-vivo fluorescence lifetime (FLT) imaging, utilizing PD-L1-targeted probes, provides quantitative estimates of PD-L1 heterogeneity across tumors, showing promise for clinical translation of FLT imaging.
AB - Cancer immunotherapy relies on PD-L1 expression, often assessed through immunohistochemistry, offering limited insights. In-vivo fluorescence lifetime (FLT) imaging, utilizing PD-L1-targeted probes, provides quantitative estimates of PD-L1 heterogeneity across tumors, showing promise for clinical translation of FLT imaging.
UR - https://www.scopus.com/pages/publications/85211740607
UR - https://www.scopus.com/inward/citedby.url?scp=85211740607&partnerID=8YFLogxK
U2 - 10.1364/ots.2024.om1d.6
DO - 10.1364/ots.2024.om1d.6
M3 - Conference contribution
AN - SCOPUS:85211740607
T3 - Optical Tomography and Spectroscopy, OT and S 2024 in Proceedings Optica Biophotonics Congress: Biomedical Optics 2024, Translational, Microscopy, OCT, OTS, BRAIN - Part of Optica Biophotonics Congress: Biomedical Optics
BT - Optical Tomography and Spectroscopy, OT and S 2024 in Proceedings Optica Biophotonics Congress
PB - Optical Society of America
T2 - Optical Tomography and Spectroscopy, OT and S 2024 - Part of Optica Biophotonics Congress: Biomedical Optics
Y2 - 7 April 2024 through 10 April 2024
ER -